Skip to main content
Caplight Logo









Precise Health SA

Precise Health SA

Private
SwitzerlandHealthcare & Life Scienceshttps://precisehealth.io/

Last Round

Grant

Jun 15, 2026

Total Funding Raised

$1.23M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Precise Health SA is a biotechnology company that develops an AI-powered platform for bacteriophage discovery, matching, and engineering to treat multidrug-resistant bacterial infections.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical AI, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

bacteriophage therapyphage matchingphage therapymultidrug-resistant infectionsphage engineeringin silico drug discoveryprecision medicineclinical decision supportantimicrobial resistanceAMRgenomics platformbiotech softwarephage bankAI drug discoveryphage-based medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Precise Health SA Comparables

Compare Precise Health SA with similar companies based on industry and business-model similarity.

Precise Health SA comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PrecisionPhage
81%
Tolka AI Therapeutics
80%
Rime Bioinformatics
78%

Precise Health SA Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 15, 2026
GrantSep 1, 2025
GrantDec 10, 2024

Key People

Founding team and executive leadership

José Luis Bila

CEO & Co-Founder

Founding Team

Precise Health SA Investors

Notable investors and investment history

Precise Health SA investors
InvestorRounds
InnosuisseGrant
Venture KickGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 15, 2026

    Secured $1.13M in grant funding from Innosuisse.

  • Sep 1, 2025

    $50K grant received from the City of Sion.

Precise Health SA Filings

Explore SEC and related filing metadata, where available.

Precise Health SA filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Precise Health SA's valuation, stock price, and market status.

Is Precise Health SA a public or private company?

Precise Health SA is a private company.

What is the current stock price of Precise Health SA?

Precise Health SA is a private company with no public stock price. No recent secondary market data is available.

How much is Precise Health SA worth (valuation)?

Valuation information for Precise Health SA is not publicly available.

Can I buy Precise Health SA stock?

Precise Health SA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Precise Health SA's last funding round?

Precise Health SA's most recent funding round was Grant on June 15, 2026.

Who are the main investors in Precise Health SA?

Key investors in Precise Health SA include Innosuisse, Venture Kick.

Will Precise Health SA IPO soon?

No public IPO plans have been announced for Precise Health SA.

How can I track Precise Health SA secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Precise Health SA's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSwitzerland
Employee Range8
Year Founded2023
Last FundingJun 15, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?